News & Events
-
Congressional Testimony 2002
FDA Statements
-
December
- 12/11/2002
Concerns Regarding Accutane (isotretinoin)
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 12/10/2002
Ongoing Response to Vaccines and Autism Issues
Karen Midthun, M.D., before the House Committee on Government Reform
-
-
November
- 11/14/2002
Regulation of Dental Amalgams
David W. Feigal, M.D., M.P.H., before the House Committee on Government Reform
-
-
October
- 10/09/2002
Implementation of the Drug Price Competition and Patent Term Restoration Act of 1984
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 10/08/2002
Regulatory Framework of DSHEA of 1994
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring and the District of Columbia - 10/03/2002
Response to the Emerging Threat of West Nile Virus (WNV)
Jesse L. Goodman, M.D., M.P.H., before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources
-
-
September
- 09/24/2002
Response to the Emerging Threat of Transmission of West Nile Virus (WNV) Through Blood and Tissue
Jesse Goodman, M.D., M.P.H., before the Senate Committee on Governmental Affairs, and the Committee on Health, Education, Labor, and Pensions, Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia
-
-
August
- 08/05/2002
Ensuring Safe FDA-regulated Products at the Port of Tampa
Gary J. Dykstra, before the House Committee on Government Reform, Subcommittee on National Security, Veterans Affairs and International Relations
-
-
July
- 07/31/2002
Dietary Supplements and Their Use for Weight-loss Purposes
Joseph A. Levitt, Esq., before the Senate Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring, and the District of Columbia - 07/25/2002
The Importation of Drugs into the United States
William K. Hubbard, before the House Committee on Energy and Commerce, Subcommittee on Health - 07/09/2002
Importation of Drugs
William K. Hubbard, before the Senate Special Committee on Aging
-
-
June
- 06/12/2002
Current Shortage of Childhood Vaccines
Lester M. Crawford, D.V.M., Ph.D., before the Senate Committee on Governmental Affairs
-
-
April
- 04/30/2002
Safety of Federal School Lunches
Lester M. Crawford, D.V.M., Ph.D., before the Committee on Governmental Affairs, Subcommittee on Oversight of Government Management, Restructuring and the District of Columbia
-
-
March
- 03/21/2002
Fiscal Year 2003 Budget Request
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies - 03/06/2002
Success in Implementing the Prescription Drug User Fee Act (PDUFA)
Lester M. Crawford, D.V.M., Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health
-
-
February
- 02/28/2002
Mammography Quality Standards Act (MQSA) of 1992
Written Statement for the Record, before the Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Public Health, and the Committee on Appropriations, Subcommittee on Labor, Health and Human Services, and Education - 02/12/2002
Oxycontin: Balancing Risks and Benefits
John K. Jenkins, M.D., before the Senate Committee on Health, Education, Labor, and Pensions
-
-
-